Karen Sims

Insider Reports History

Location
Warminster, PA
Signature
/s/ David C. Hastings as attorney-in-fact for Karen Sims
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Karen Sims:

Company Role Class Num Shares Value Price $ Report Date Ownership
Arbutus Biopharma Corp Chief Medical Officer Common Shares 155,494 $510,487 $3.28 14 Feb 2025 Direct
Arbutus Biopharma Corp Chief Medical Officer Stock Option (Right to Buy) 200,300 14 Feb 2025 Direct

Insider Reports Filed by Karen Sims

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ABUS Arbutus Biopharma Corp 14 Feb 2025 2 $0 4 Chief Medical Officer 19 Feb 2025, 18:25
ABUS Arbutus Biopharma Corp 04 Feb 2025 1 -$63,519 4 Chief Medical Officer 05 Feb 2025, 16:02
ABUS Arbutus Biopharma Corp 01 Feb 2024 3 -$10,078 4 Chief Medical Officer 05 Feb 2024, 19:55
ABUS Arbutus Biopharma Corp 10 Jul 2023 1 $0 4 Chief Medical Officer 12 Jul 2023, 16:50
ABUS Arbutus Biopharma Corp 10 Jul 2023 0 $0 3 Chief Medical Officer 12 Jul 2023, 16:48